"CD Diagnostics, Inc. - Product Pipeline Analysis" Is Now Available at Fast Market Research
CD Diagnostics, Inc. (CD Diagnostics) is immunoassays developer. The company's technology aims to detect the causes of joint pain using joint fluid analysis. The assays measure the presence of biomarkers, a protein which is specific to a particular joint disease, through a sample of synovial fluid. CD Diagnostics will launch its first immunoassay for joint infection. It has various tests in development stage for other joint diseases, including gout, rheumatoid arthritis, pseudogout and osteoarthritis. The company has trademark for CygnaSure....
View full press release